Dr. Reddy’s Laboratories Ltd ADR (RDY) — the earnings record

Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.

The record at a glance

6/10EPS beats
6/10revenue beats
3 · 4 · 3up · flat · down (+3d, ±3%)
2026-10-23next print

Reactions across the covered prints span -8.0% to +5.7% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $0.10 · est revenue ~$0.84B into the next print.

Print by print

PrintDateEPSRevenue
Jul 26 2026-07-21 ✗ miss ✗ miss
May 26 2026-05-11 ✗ miss ✗ miss
Jan 26 2026-01-20 ✗ miss ✓ beat
Oct 25 2025-10-24 ✓ beat ✓ beat
Jul 25 2025-07-23 ✓ beat ✗ miss
May 25 2025-05-09 ✓ beat ✓ beat
Jan 25 2025-01-29 ✓ beat ✗ miss
Nov 24 2024-11-05 ✗ miss ✓ beat
Jul 24 2024-07-27 ✓ beat ✓ beat
May 24 2024-05-07 ✓ beat ✓ beat

Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for RDY yet.

FAQ · from the current data · as of 2026-09-18

Quick answers

How often does Dr. Reddy’s Laboratories Ltd ADR beat earnings estimates?

Across the last 10 covered prints (as of the 2026-09-18 card), Dr. Reddy’s Laboratories Ltd ADR beat EPS estimates 6 of 10 times and revenue estimates 6 of 10 times, with 4 double beats.

How does RDY stock react to earnings?

Measured close-of-print-day to the close three sessions later: 3 of the last 10 prints resolved up (beyond +3%), 4 flat, 3 down — reactions spanning -8.0% to +5.7%. Beat-or-miss and reaction are scored separately because they frequently disagree.

What was RDY's biggest earnings reaction?

-8% over the three sessions after the Oct 25 print (2025-10-24).

When does Dr. Reddy’s Laboratories Ltd ADR report earnings next?

2026-10-23 (2026-10-23 · est EPS $0.10 · est revenue ~$0.84B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for RDY does not exist yet. An investment research diary, not advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.